Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Omeprazole and PGC-formulated heparin binding epidermal growth factor normalizes fasting blood glucose and suppresses insulitis in multiple low dose streptozotocin diabetes model.

Castillo GM, Nishimoto-Ashfield A, Banerjee AA, Landolfi JA, Lyubimov AV, Bolotin EM.

Pharm Res. 2013 Nov;30(11):2843-54. doi: 10.1007/s11095-013-1112-6. Epub 2013 Jun 21.

2.

Pharmacological treatment of chronic diabetes by stimulating pancreatic beta-cell regeneration with systemic co-administration of EGF and gastrin.

Brand SJ, Tagerud S, Lambert P, Magil SG, Tatarkiewicz K, Doiron K, Yan Y.

Pharmacol Toxicol. 2002 Dec;91(6):414-20. Review.

PMID:
12688387
3.
4.

Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets.

Suarez-Pinzon WL, Rabinovitch A.

Transplant Proc. 2008 Mar;40(2):529-32. doi: 10.1016/j.transproceed.2008.01.005.

PMID:
18374121
5.

Anti-diabetic effects of shubat in type 2 diabetic rats induced by combination of high-glucose-fat diet and low-dose streptozotocin.

Manaer T, Yu L, Zhang Y, Xiao XJ, Nabi XH.

J Ethnopharmacol. 2015 Jul 1;169:269-74. doi: 10.1016/j.jep.2015.04.032. Epub 2015 Apr 25.

PMID:
25922265
6.

Protective and antidiabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluation.

Alimohammadi S, Hobbenaghi R, Javanbakht J, Kheradmand D, Mortezaee R, Tavakoli M, Khadivar F, Akbari H.

Diagn Pathol. 2013 Aug 15;8:137. doi: 10.1186/1746-1596-8-137. Retraction in: Diagn Pathol. 2016 Nov 2;11(1):125.

7.

Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice.

Patel V, Joharapurkar A, Dhanesha N, Kshirsagar S, Detroja J, Patel K, Gandhi T, Patel K, Bahekar R, Jain M.

Pharmacol Rep. 2013;65(4):927-36.

8.

Gastrin enhances the angiogenic potential of endothelial cells via modulation of heparin-binding epidermal-like growth factor.

Clarke PA, Dickson JH, Harris JC, Grabowska A, Watson SA.

Cancer Res. 2006 Apr 1;66(7):3504-12.

9.

Hypogastrinemia in streptozotocin diabetes with islet transplantation--reconstitution.

Fabri PJ, Weber CJ, Gower WR Jr, Reemtsma K.

J Surg Res. 1983 May;34(5):432-7.

PMID:
6405099
10.

Protected graft copolymer (PGC) basal formulation of insulin as potentially safer alternative to Lantus® (insulin-glargine): a streptozotocin-induced, diabetic Sprague Dawley rats study.

Reichstetter S, Castillo GM, Lai M, Nishimoto-Ashfield A, Banerjee A, Bogdanov A, Lyubimov AV, Bolotin EM.

Pharm Res. 2012 Apr;29(4):1033-9. doi: 10.1007/s11095-011-0646-8. Epub 2011 Dec 28.

PMID:
22203325
11.

Human trophoblast survival at low oxygen concentrations requires metalloproteinase-mediated shedding of heparin-binding EGF-like growth factor.

Armant DR, Kilburn BA, Petkova A, Edwin SS, Duniec-Dmuchowski ZM, Edwards HJ, Romero R, Leach RE.

Development. 2006 Feb;133(4):751-9. Epub 2006 Jan 11.

12.

Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice.

Suarez-Pinzon WL, Yan Y, Power R, Brand SJ, Rabinovitch A.

Diabetes. 2005 Sep;54(9):2596-601.

13.

Epidermal growth factor and gastrin on PDX1 expression in experimental type 1 diabetic rats.

Yu H, Sun Z, Cui J, Song G, Wang F, Gao F, Liu X, Wang X, Ni J.

Am J Med Sci. 2012 Feb;343(2):141-5. doi: 10.1097/MAJ.0b013e31822423793.

PMID:
22270267
14.

Diminished survival of human cytotrophoblast cells exposed to hypoxia/reoxygenation injury and associated reduction of heparin-binding epidermal growth factor-like growth factor.

Leach RE, Kilburn BA, Petkova A, Romero R, Armant DR.

Am J Obstet Gynecol. 2008 Apr;198(4):471.e1-7; discussion 471.e7-8. doi: 10.1016/j.ajog.2008.01.009.

15.

Improving the anti-diabetic activity of GLP-1 by fusion with globular adiponectin.

Gao M, Tong Y, Li W, Gao X, Yao W.

Artif Cells Nanomed Biotechnol. 2013 Jun;41(3):159-64. doi: 10.3109/10731199.2012.712042. Epub 2012 Aug 14.

PMID:
22889326
16.

Function-specific intracellular signaling pathways downstream of heparin-binding EGF-like growth factor utilized by human trophoblasts.

Jessmon P, Kilburn BA, Romero R, Leach RE, Armant DR.

Biol Reprod. 2010 May;82(5):921-9. doi: 10.1095/biolreprod.109.082305. Epub 2010 Feb 3.

17.

Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice.

Suarez-Pinzon WL, Power RF, Yan Y, Wasserfall C, Atkinson M, Rabinovitch A.

Diabetes. 2008 Dec;57(12):3281-8. doi: 10.2337/db08-0688. Epub 2008 Oct 3.

18.

A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice.

Rosenberg L, Lipsett M, Yoon JW, Prentki M, Wang R, Jun HS, Pittenger GL, Taylor-Fishwick D, Vinik AI.

Ann Surg. 2004 Nov;240(5):875-84.

19.

Supplemental Content

Support Center